ALLO - Allogene Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ALLO is currently covered by 7 analysts with an average price target of $7.97. This is a potential upside of $6.64 (499.25%) from yesterday's end of day stock price of $1.33.

Allogene Therapeutics's activity chart (see below) currently has 176 price targets and 164 ratings on display. The stock rating distribution of ALLO is 22.22% HOLD, 66.67% BUY and 11.11% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 21.16% with an average time for these price targets to be met of 58.63 days.

Highest price target for ALLO is $11, Lowest price target is $3.85, average price target is $7.97.

Most recent stock forecast was given by RENI BENJAMIN from JMP on 17-Aug-2026. First documented stock forecast 05-Nov-2018.

Currently out of the existing stock ratings of ALLO, 2 are a HOLD (22.22%), 6 are a BUY (66.67%), 1 are a SELL (11.11%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 17-Aug-2026

$6

$4.69 (358.02%)

$5

2 months 5 days ago
(17-Aug-2026)

1/10 (10%)

$3.92 (188.46%)

148

Buy Since 15-Apr-2026

$10

$8.5 (566.67%)

$10

6 months ago
(22-Apr-2026)

0/2 (0%)

$7.61 (318.41%)

Buy Since 04-Apr-2023

$11

$8.87 (416.43%)

$12

6 months 6 days ago
(16-Apr-2026)

0/12 (0%)

$8.63 (364.14%)

Sell Since 16-Apr-2026

6 months 6 days ago
(16-Apr-2026)

0/3 (0%)

$2.86 (55.64%)

Hold Since 21-Mar-2023

$3.85

$1.72 (80.75%)

$2.5

6 months 8 days ago
(14-Apr-2026)

2/3 (66.67%)

$1.13 (41.54%)

155

Show more analysts

Please expand the browser size to see the chart

What is ALLO (Allogene Therapeutics) average time for price targets to be met?

On average it took 59 days for the stock forecasts to be reached, with an average price target met ratio of 21.16%.

Which analyst most recently updated their price target on ALLO (Allogene Therapeutics)?

Reni Benjamin

Which analyst has the most public recommendations on ALLO (Allogene Therapeutics)?

Reni Benjamin works at JMP and has 3 price targets and 1 ratings on ALLO

Which analyst is the currently most bullish on ALLO (Allogene Therapeutics)?

Salveen Richter with the highest potential upside of $29.69

Which analyst is the currently most reserved on ALLO (Allogene Therapeutics)?

Asthika Goonewardene with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?